Andrew Spaventa Singular Genomics Systems, Inc. (OMIC) insider trading activity
Andrew Spaventa is Chief Executive Officer of Singular Genomics Systems, Inc.. Currently has a direct ownership of 325 shares of OMIC, which is worth approximately $6,961. The most recent transaction as insider was on Nov 12, 2024, when has been sold 1,212 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
325
0%
3M change
96.67%
12M change
Total Value Held
$6,961
Andrew Spaventa Transaction History
AS
Andrew Spaventa
Chief Executive Officer
La Jolla, CA